Financial Analysis and Performance Evaluation of Moderna

Abstract

The report analyses the financial performance of Moderna Inc for the past four years. Moderna Inc is a biotechnological company that focuses on the development of vaccines using messenger ribonucleic acid (mRNA) technology. The study collected data about the company from secondary sources which are Yahoo Finance and Nasdaq websites. The report analyzed the financial performance of the company by computing profitability ratios, cash flow ratios, leverage ratios, and liquidity ratios. The study concluded by giving recommendations on what the company can do to improve its financial performance in the future.